Researchers report that a simple blood test could identify people at higher risk of Alzheimer’s-related cognitive decline up to a decade before symptoms appear. The findings come from a major international study published in JAMA, which links test results to later impairment related to Alzheimer’s.
Across the sources, the emphasis is on early detection and the potential for earlier intervention. The reports describe that, among the highest-risk individuals, impairment is estimated at a 38% chance within five years and about 78% within ten years, although the intent is framed as predicting cognitive decline rather than diagnosing established Alzheimer’s symptoms. Both accounts suggest the discovery could support future efforts to test whether earlier detection leads to prevention or delayed onset of memory problems, aligning with broader goals in Alzheimer’s research.
